These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10720202)

  • 1. Effects of radiation on a model of malignant glioma invasion.
    Bauman GS; MacDonald W; Moore E; Ramsey DA; Fisher BJ; Amberger VR; Del Maestro RM
    J Neurooncol; 1999; 44(3):223-31. PubMed ID: 10720202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging response in malignant glioma, RTOG 90-06.
    Lustig RA; Seiferheld W; Berkey B; Yung AW; Scarantino C; Movsas B; Jones CU; Simpson JR; Fishbach J; Curran WJ
    Am J Clin Oncol; 2007 Feb; 30(1):32-7. PubMed ID: 17278892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of radiation on a three-dimensional model of malignant glioma invasion.
    Bauman GS; Fisher BJ; McDonald W; Amberger VR; Moore E; Del Maestro RF
    Int J Dev Neurosci; 1999; 17(5-6):643-51. PubMed ID: 10571424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
    Levin VA; Wilson CB; Davis R; Wara WM; Pischer TL; Irwin L
    J Neurosurg; 1979 Oct; 51(4):526-32. PubMed ID: 225456
    [No Abstract]   [Full Text] [Related]  

  • 5. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme.
    Limentani SA; Asher A; Heafner M; Kim JW; Fraser R
    J Neurooncol; 2005 May; 72(3):241-4. PubMed ID: 15937647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC; Gaspar L; Imperato J; Salter M; Herndon J; Dowling S
    Am J Clin Oncol; 1993 Aug; 16(4):277-83. PubMed ID: 8392285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F; Prados M; Russell C; Weissman D; Evans R; Cook P; Burton G; Eisenberg PD; Valenzuela R; Verkh L
    J Neurooncol; 1997 Mar; 32(1):45-55. PubMed ID: 9049862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting enhances the response of glioma to chemo- and radiotherapy.
    Safdie F; Brandhorst S; Wei M; Wang W; Lee C; Hwang S; Conti PS; Chen TC; Longo VD
    PLoS One; 2012; 7(9):e44603. PubMed ID: 22984531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
    Deutsch M; Green SB; Strike TA; Burger PC; Robertson JT; Selker RG; Shapiro WR; Mealey J; Ransohoff J; Paoletti P
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1389-96. PubMed ID: 2542193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine.
    Arrieta O; Guevara P; Reyes S; Ortiz A; Rembao D; Sotelo J
    Eur J Cancer; 1998 Dec; 34(13):2101-6. PubMed ID: 10070318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.
    Branle F; Lefranc F; Camby I; Jeuken J; Geurts-Moespot A; Sprenger S; Sweep F; Kiss R; Salmon I
    Cancer; 2002 Aug; 95(3):641-55. PubMed ID: 12209758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
    Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-6 essential fatty acids on glioma invasion and growth: experimental studies with glioma spheroids in collagen gels.
    Bell HS; Wharton SB; Leaver HA; Whittle IR
    J Neurosurg; 1999 Dec; 91(6):989-96. PubMed ID: 10584845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
    Ali AN; Zhang P; Yung WKA; Chen Y; Movsas B; Urtasun RC; Jones CU; Choi KN; Michalski JM; Fischbach AJ; Markoe AM; Schultz CJ; Penas-Prado M; Garg MK; Hartford AC; Kim HE; Won M; Curran WJ
    J Neurooncol; 2018 Mar; 137(1):39-47. PubMed ID: 29404979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of cycloheximide on neuronal and glioma cells treated with chemotherapy and radiation.
    Chao KS; Hsu JS; Xu J; Ezekiel UR; Eves E; Rosner M; Hsu CY
    J Neurooncol; 1999; 45(1):19-26. PubMed ID: 10728906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
    Brem H; Ewend MG; Piantadosi S; Greenhoot J; Burger PC; Sisti M
    J Neurooncol; 1995 Nov; 26(2):111-23. PubMed ID: 8787853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of human glioma cell lines to low-dose radiation exposure.
    Short SC; Mitchell SA; Boulton P; Woodcock M; Joiner MC
    Int J Radiat Biol; 1999 Nov; 75(11):1341-8. PubMed ID: 10597908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y
    Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Shibamoto Y
    Am J Clin Oncol; 1995 Oct; 18(5):449-53. PubMed ID: 7572767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
    Buckner JC; Schomberg PJ; McGinnis WL; Cascino TL; Scheithauer BW; O'Fallon JR; Morton RF; Kuross SA; Mailliard JA; Hatfield AK; Cole JT; Steen PD; Bernath AM
    Cancer; 2001 Jul; 92(2):420-33. PubMed ID: 11466698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.